Trial reportBMJ open2025
Impact of silicone midline catheter tip location on catheter-related complications and indwelling duration: results from a multicentre randomised clinical trial in China.
Trial report in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07792642 (FITME Study), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the impact of the terminal tip location of silicone midline catheter (MC, a type of intravenous catheter measuring 20-30 cm in length and inserted into upper arm veins using a modified Seldinger technique) in the subclavian vein group versus axillary vein group on catheter-related complications and indwelling duration.
designThis is a randomised controlled study.
settingTwenty-seven tertiary hospitals in China.
participantsBetween September 2022 and October 2023, 2307 patients underwent MC placement and were randomly assigned to either the axillary vein group (n=1124) or the subclavian vein group (n=1183). OUTCOME MEASURES: There were two outcome measures: one was to compare the incidence of catheter-related complications (eg, catheter-related thrombosis, infection, catheter occlusion, etc.) between the two groups, and the other was to compare the indwelling duration between the groups.
resultsThe total observed incidence of catheter-related complications in the axillary vein group and subclavian vein group was 1.0% (11/1124) and 0.8% (10/1183), respectively. There was no statistically significant difference in the total incidence of catheter-related complications. The median indwelling duration (median (IQR)) of the two groups was 10 days (7, 15) and 10 days (7, 15), respectively. The two groups had no statistical difference in the indwelling duration.
conclusionsOur findings suggested that the terminal tip of silicone MC in the subclavian vein would not increase the incidence of catheter-related complications. Silicone MC was a safe catheter for the low incidence of catheter-related complications and could be popularised in clinical practice. TRIAL REGISTRATION NUMBER: ChiCTR2200058942; Chinese Clinical Trial Registry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.